Raynews

Rayner continues European growth with direct presence in France

Posted on 11/07/2022

Worthing, United Kingdom. Leading ophthalmology company Rayner has today announced its direct entry into the French cataract and refractive market. Based out of Lille in the Hauts-de-France region, Rayner has a growing team of experienced Ophthalmic Specialist Area Managers, focused on delivering the highest levels of service and support. Through this team, French ophthalmologists now

Read more


Rayner encourages surgeons to ‘do the talking’ with the launch of the Peer2Peer clinical program and resource hub

Posted on 29/06/2022

Today, Rayner has launched Peer2Peer: a global KOL-led clinical education program focused on the most important topics in cataract and refractive surgery – including presbyopia correction, advanced IOL design, astigmatism correction, dry eye management and digital health. Peer2Peer is an evolution of Rayner’s ‘Plus1 EMV’ program; now with first users, experienced users and thought provokers

Read more


Rayner Acquires Stake in Sustainable Surgical Instrument Belgian Manufacturer HASA OPTIX

Posted on 8/06/2022

Worthing, United Kingdom. Rayner, the pioneering manufacturer and supplier of ophthalmic solutions for cataract and refractive surgery, announced today that it has entered into a commercial partnership and concurrently acquired a stake in HASA OPTIX. The investment closed June 7th, 2022. Investment Details Rayner has entered into a commercial partnership with Brussels-based medical device company

Read more


AEON eye drops now available in Boots Opticians across the UK

Posted on 31/05/2022

May 19, 2022 – Worthing-based Rayner, a global innovator in cataract and refractive surgery solutions and the only UK manufacturer of intraocular lenses (IOLs), announced today that AEON, its surgery-focused premium eye drops are now available in one of the leading UK optician chains, Boots Opticians, with more than 500 branches across the UK. In the UK,

Read more


Rayner partners with Wolffsohn Research to extend its digital health leadership

Posted on 22/02/2022

FEBRUARY 22 2022 – Worthing, United Kingdom. Rayner, a global innovator in cataract and refractive surgery, announced today that it has agreed a development partnership with Wolffsohn Research Ltd to accelerate the development of its Digital Health platform. Rayner launched RayPRO, a digital platform to collect patient reported outcomes (PRO), in 2019 and has since collected data

Read more


Rayner opens regional office in Australia as global commercial growth continues

Posted on 19/01/2022

JANUARY 19, 2022 – Worthing, United Kingdom. Rayner, a leading ophthalmology company and the only British manufacturer of intraocular lenses (IOLs), announced today that it now has a direct sales presence in Australia as it continues its global commercial expansion. Previously distributed through Designs For Vision, Rayner will now sell its products directly to surgeons and hospitals

Read more


Rayner expands RayOne portfolio with first blue light filtering IOL

Posted on 5/01/2022

JANUARY 05, 2022 – Worthing, United Kingdom. Rayner, the only UK manufacturer of intraocular lenses (IOLs), today announced the launch of RayOne Hydrophobic BLF. Made of its proprietary ultra glistening-free hydrophobic material, RayOne Hydrophobic BLF is Rayner’s first blue light filtering IOL. RayOne Hydrophobic BLF expands Rayner’s RayOne lens portfolio from seven to eight variants, now with

Read more


Rayner appoints esteemed ophthalmic leaders as strategic advisors and is awarded IDE for trifocal IOLs

Posted on 22/12/2021

DECEMBER 22, 2021 – Worthing, United Kingdom. Rayner, a leading UK-based ophthalmic company focused on optimising visual outcomes for surgeons and their patients, is delighted to announce the appointment of Drs Eric Donnenfeld, Kerry Solomon, Vance Thompson, and Mr Jim Mazzo as strategic advisors to the business, with a specific focus on supporting the expansion

Read more


Rayner acquires Omidria to expand surgical offering in USA and Europe

Posted on 2/12/2021

DECEMBER 02, 2021 – Worthing, United Kingdom. Rayner Surgical Group (‘Rayner’) and Omeros Corporation (‘Omeros’) are delighted to announce the transfer of Omeros’ ophthalmology assets, including OmidriaTM, to Rayner. This will enable the creation of a significant commercial, regulatory and marketing infrastructure in the US, with a broad range of products, including intraocular lenses (IOLs), for cataract surgeons.

Read more


Rayner appoints VP Corporate Development to lead global commercial expansion

Posted on 24/11/2021

NOVEMBER 24, 2021 – Worthing, United Kingdom. Rayner, a leading ophthalmology company focused on optimising visual outcomes for patients and surgeons, today announced the appointment of Dr Rob Nadler to the role of VP Corporate Development. Dr Nadler will play a critical role on the executive team, overseeing the company’s M&A strategy and brings invaluable clinical,

Read more